Shares of Becton Dickinson Rise to a New 52-Week High
Becton Dickinson (NYSE:BDX) traded today at a new 52-week high of $177.40. Approximately 71,000 shares have changed hands today, as compared to an average 30-day volume of 885,000 shares.
Becton, Dickinson and Company manufactures and sells a variety of medical supplies and devices and diagnostic systems. The Company's products are used by health care professionals, medical research institutions, and the general public. Becton's products are marketed worldwide.
Becton Dickinson (NYSE:BDX) defies analysts with a current price ($177.19) 7.3% above its average consensus price target of $164.29. The stock should find initial support at its 50-day moving average (MA) of $153.96 and further support at its 200-day MA of $147.03.
In the past 52 weeks, shares of Becton Dickinson have traded between a low of $128.87 and a high of $177.40 and are now at $177.19, which is 37% above that low price. Over the past week, the 200-day moving average (MA) has gone up 0.2% while the 50-day MA has advanced 0.8%.
SmarTrend recommended that subscribers consider buying shares of Becton Dickinson on February 17th, 2016 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $143.14. Since that recommendation, shares of Becton Dickinson have risen 22.9%. We continue to monitor BDX for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.
Keywords: 52 week high/lows becton dickinson